BridgeBio Pharma Inc. (BBIO)
35.00
-0.60 (-1.70%)
At close: Jan 15, 2025, 11:46 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -10.22 | -2.27 | -3.77 | -17.34 | -14.14 | -19.45 | -83.22 |
| PS Ratio | 706.43 | 14.47 | 34.54 | 1.02K | 90.82 | n/a | n/a |
| PB Ratio | -4.85 | -0.9 | -2.77 | 144.90 | 9.02 | -15.51 | -43.84 |
| P/FCF Ratio | -12.42 | -2.64 | -4.41 | -20.6 | -14.24 | -16.43 | -62.11 |
| P/OCF Ratio | -12.45 | -2.68 | -4.84 | -20.99 | -14.53 | -18.62 | -62.83 |
| OCF/S Ratio | -56.73 | -5.4 | -7.14 | -48.46 | -6.25 | n/a | n/a |
| Debt / Equity Ratio | -1.28 | -1.37 | -1.98 | 8.56 | 0.24 | -0.33 | -2.48 |
| Quick Ratio | 3.32 | 3.97 | 6.98 | 7.00 | 11.45 | 13.67 | 11.36 |
| Current Ratio | 3.32 | 4.29 | 6.45 | 7.00 | 11.45 | 13.67 | 11.36 |
| Asset Turnover | 0.02 | 0.12 | 0.07 | 0.01 | 0.06 | n/a | n/a |
| Interest Coverage | -7.47 | -5.87 | -12.39 | -12.94 | -30.38 | -72.11 | -3.37K |
| Return on Equity (ROE) | 0.47 | 0.39 | 0.73 | -8.36 | -0.64 | 0.80 | 0.53 |
| Return on Assets (ROA) | -1.18 | -0.79 | -0.63 | -0.69 | -0.41 | -0.28 | -0.31 |
| Return on Capital (ROIC) | -1.51 | -0.93 | -0.66 | -0.78 | -0.46 | -0.42 | -0.49 |
| Dividend Yield | n/a | n/a | n/a | n/a | 0.00 | n/a | 0.00 |
| Payout Ratio | n/a | n/a | n/a | n/a | -0.00 | n/a | -0.04 |
| Gross Profit Margin | 73.71% | 95.58% | 95.53% | 62.57% | 93.84% | n/a | n/a |
| Net Profit Margin | -6.91K% | -636.16% | -917% | -5.87K% | -642.1% | n/a | n/a |
| Pretax Profit Margin | -7.02K% | -624.17% | -841.2% | -6.13K% | -711.5% | n/a | n/a |
| Operating Profit Margin | -6.53K% | -607.71% | -831.58% | -5.75K% | -656.41% | n/a | n/a |
| FCF Margin | -5.69K% | -548.39% | -783.44% | -4.94K% | -637.88% | n/a | n/a |
| EBITDA Margin | -6.08K% | -511.85% | -765.73% | -5.65K% | -689.89% | n/a | n/a |